Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Global Acne Market 2014-2018

Published: Nov-2014 | Format: PDF | Technavio | Number of pages: 72 | Code: MRS - 15243

 

Acne is one of the common dermatological disorders. Acne, or acne vulgaris is an inflammatory disorder of the skin which affects people of almost all age groups. The exact etiology of acne is not fully understood. Although acne does not present a serious threat to health, severe acne can not only be painful, but also affect a patient's quality of life. Topical medications, oral medications, or a combination of all are some of the treatment options available for acne.

TechNavio's analysts forecast the Global Acne market to grow at a CAGR of 4.07 percent over the period 2013-2018.

Covered in this Report

The Global Acne market can be divided into seven segments: Antibiotics, Anti-Inflammatories, Antimicrobials, Combination Medications, Hormonal Agents, Oral Retinoid, and Topical Retinoid. This report covers the present scenario and the growth prospects of the Global Acne market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and topical creams used in the treatment of acne that are available in the market.

TechNavio's report, the Global Acne Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Acne market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

Americas
EMEA
APAC

Key Vendors

Actavis
Allergen
Galderma
Stiefel Laboratories
Valeant Pharmaceuticals International

Other Prominent Vendors

Andro Science
Bayer
Cipher Pharmaceuticals
Cosmo Pharmaceuticals
Elorac
Foamix Pharmaceuticals
Helix BioMedix
Hygeia Therapeutics
IMTM
J&J
Mylan Pharmaceuticals
NanoBio
NovaLead Pharma
F. Hoffmann-La Roche

Market Driver

Significant Unmet Needs
For a full, detailed list, view our report

Market Challenge

High Cost of Acne Drugs
For a full, detailed list, view our report

Market Trend

Increased Focus on Combination Therapies
For a full, detailed list, view our report

Key Questions Answered in this Report

What will the market size be in 2018 and what will the growth rate be
What are the key market trends
What is driving this market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the key vendors
What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
07. Implications of Acne
07.1 Five Forces Analysis

08. Types and Characteristics of Acne

09. Competitive Assessment of Marketed Products

10. Rate of Incidence and Prevalence
10.1.1 US
10.1.2 UK

11. Market Segmentation by Category

12. Geographical Segmentation

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2013
20.3 Other Prominent Vendors

21. Key Vendor Analysis
21.1 Actavis plc
21.1.1 Key Facts
21.1.2 Business Description
21.1.3 Business Segmentation
21.1.4 Business Segmentation by Revenue 2012 and 2013
21.1.5 Sales by Geography
21.1.6 Business Strategy
21.1.7 Key Information
21.1.8 SWOT Analysis
21.2 Allergan Inc.
21.2.1 Key Facts
21.2.2 Business Description
21.2.3 Business Segmentation
21.2.4 Revenue by Business Segmentation
21.2.5 Revenue Comparison 2011-2013
21.2.6 Revenue by Geographical Segmentation
21.2.7 Business Strategy
21.2.8 Key Developments
21.2.9 SWOT Analysis
21.3 Galderma
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Product Segmentation by Revenue 2013
21.3.4 Geographical Segmentation by Revenue 2013
21.3.5 Business Strategy
21.3.6 Recent Developments
21.3.7 SWOT Analysis
21.4 Stiefel Laboratories
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Product Segmentation
21.4.4 Geographical Segmentation by Revenue 2013
21.4.5 Business Strategy
21.4.6 Recent Developments
21.4.7 SWOT Analysis
21.5 Valeant Pharmaceuticals International Inc.
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2013
21.5.4 Business Segmentation by Revenue 2012 and 2013
21.5.5 Sales by Geography
21.5.6 Business Strategy
21.5.7 Key Developments
21.6 SWOT Analysis

List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: Global Acne Market 2013-2018 (US$ billion)
Exhibit 4: Global Acne Market Segmentation by Category
Exhibit 5: Global Acne Market by Geographical Segmentation 2013
Exhibit 6: Allergen Sales by Portfolio 2012
Exhibit 7: Galderma Sales by Therapeutic Area 2012
Exhibit 8: Global Acne marketBusiness Segmentation 2013
Exhibit 9: Global Acne market Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 10: Actavis Plc: Sales by Geography (in US$ million)
Exhibit 11: Allergan Inc.: Business Segmentation
Exhibit 12: Allergan Inc.: Revenue by Business Segmentation 2013
Exhibit 13: Allergan Inc.: Revenue Comparison by Business Segmentation 2011-2013 (US$ billion)
Exhibit 14: Allergan Inc.: Revenue by Geographical Segmentation 2013
Exhibit 15: Galderma: Product Segmentation by Revenue 2013
Exhibit 16: Galderma: Geographical Segmentation by Revenue 2013
Exhibit 17: Stiefel Laboratories: Product Segmentation 2013
Exhibit 18: Stiefel Laboratories: Geographical Segmentation by Revenue 2013
Exhibit 19: Valeant Pharmaceuticals International Inc.: Business Segmentation by Revenue 2013
Exhibit 20: Valeant Pharmaceuticals International Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 21: Valeant Pharmaceuticals International Inc.: Sales by Geography 2013

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)2500 View Pricing